FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
(Reuters) - The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health's Monoject syringes with patient-controlled pain management pumps.
The regulator's warning comes after Cardinal Health initiated a recall for the Monoject syringes due to incompatibility concerns with syringe pumps.
Monoject-control syringes are sterile, single-use syringes without a needle while patient-controlled analgesia or pain management pumps are used to treat different kinds of pain by transferring medications intravenously.
(Reporting by Christy Santhosh; Editing by Maju Samuel)